Assembly Biosciences Inc./$ASMB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Ticker
$ASMB
Sector
Primary listing
Employees
73
Headquarters
Website
ASMB Metrics
BasicAdvanced
$481m
-
-$0.47
1.09
-
Price and volume
Market cap
$481m
Beta
1.09
52-week high
$39.71
52-week low
$16.81
Average daily volume
205k
Financial strength
Current ratio
6.647
Quick ratio
6.516
Long term debt to equity
0.957
Total debt to equity
1.254
Profitability
EBITDA (TTM)
-13.425
Gross margin (TTM)
8.77%
Net profit margin (TTM)
-8.98%
Operating margin (TTM)
-19.05%
Revenue per employee (TTM)
$970,000
Management effectiveness
Return on assets (TTM)
-5.06%
Return on equity (TTM)
-5.66%
Valuation
Price to revenue (TTM)
4.627
Price to book
1.94
Price to tangible book (TTM)
1.94
Price to free cash flow (TTM)
-8.258
Free cash flow yield (TTM)
-12.11%
Free cash flow per share (TTM)
-2.938
Growth
Revenue change (TTM)
121.11%
Earnings per share change (TTM)
-92.32%
3-year earnings per share growth (CAGR)
-72.12%
10-year earnings per share growth (CAGR)
-32.07%
ASMB News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs